Elite Pharmaceuticals, Inc. Proceeds from Related Party Debt
Elite Pharmaceuticals, Inc. (ELTP) reported Proceeds from Related Party Debt of $4.00 million for the 12-month period ending 2024-03-31, per its 10-K filed 2025-06-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2025-06-30
- Elite Pharmaceuticals, Inc. proceeds from related party debt for the quarter ending 2024-03-31 was $0.00.
- Elite Pharmaceuticals, Inc. proceeds from related party debt for the quarter ending 2023-12-31 was $0.00.
- Elite Pharmaceuticals, Inc. proceeds from related party debt for the quarter ending 2023-09-30 was $0.00.
- Elite Pharmaceuticals, Inc. proceeds from related party debt for the quarter ending 2023-06-30 was $4.00M.
- Elite Pharmaceuticals, Inc. proceeds from related party debt for fiscal 2024 was $4.00M.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month |
|---|---|---|---|---|
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-30 | $0.00 derived: sum of 2 quarters · filed 2025-06-30 | $0.00 derived: sum of 3 quarters · filed 2025-06-30 | $4.00M 10-K · filed 2025-06-30 |
| 2023-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $0.00 derived: sum of 2 quarters · filed 2025-02-13 | $4.00M 10-Q · filed 2025-02-13 | |
| 2023-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-14 | $4.00M 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $4.00M 10-Q · filed 2024-08-14 |